Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells

Publisher： John Wiley & Sons Inc

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.136, Iss.9, 2015-05, pp. : 2078-2090

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [11C]acetate PET as a prognostic marker

By  

THE PROSTATE, Vol. 270-4137, Iss. 15, 2015-11 ,pp. : 1760-1767

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [11C]acetate PET as a prognostic marker

By  

THE PROSTATE, Vol. 75, Iss. 15, 2015-11 ,pp. : 1760-1767

John Wiley & Sons Inc

Access to resources Recommend Favorite

The marine-derived fungal metabolite, terrein, inhibits cell proliferation and induces cell cycle arrest in human ovarian cancer cells

By  

International Journal of Molecular Medicine, Vol. 34, Iss. 6, 2014-01 ,pp. : 1591-1598

Spandidos Publications

Access to resources Recommend Favorite

The Risk of Ovarian Malignancy Algorithm (ROMA) as a Predictive Marker of Peritoneal Dissemination in Epithelial Ovarian Cancer Patients

By  

Oncology Research and Treatment, Vol. 38, Iss. 6, 2015-05 ,pp. : 276-281

Karger

Access to resources Recommend Favorite

CAP1 is overexpressed in human epithelial ovarian cancer and promotes cell proliferation

By                    

International Journal of Molecular Medicine, Vol. 35, Iss. 4, 2015-01 ,pp. : 941-949

Spandidos Publications

Access to resources Recommend Favorite